Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Article in English | IMSEAR | ID: sea-158051

ABSTRACT

To study the differential effects of estrogen and progestin on memory in postmenopausal women receiving hormone replacement therapy (HRT). Methods: Thirty women between ages 45 and 60 years who had attained natural menopause and received combined estrogen progestin therapy constituted group I. While group II included 30 surgically menopausal women who received only estrogen, PGI memory scale having a battery of ten subtests devised specially for Indian subjects was used. Results were analyzed by repetitive measure analysis. Results: Women showed an improved score on memory scale after 6 months of HRT in both the groups. The comparison of both groups post therapy revealed improvement in scores of delayed recall & visual retention in group II indicating that only estrogen users benefited more. Conclusion: This study supports the view that estrogens with or without progestin if given early after menopause i.e. below 60 yrs if age do have a beneficial role on memory.


Subject(s)
Adult , Estrogen Replacement Therapy/adverse effects , Estrogen Replacement Therapy/psychology , Female , Hormone Replacement Therapy/adverse effects , Hormone Replacement Therapy/psychology , Humans , Memory/drug effects , Memory/psychology , Postmenopause/drug effects , Postmenopause/psychology
2.
Reprod. clim ; 15(4): 218-22, out.-dez. 2000. tab
Article in Portuguese | LILACS | ID: lil-289129

ABSTRACT

Apesar dos reconhecidos benefícios da terapia de reposiçäo hormonal (TRH) nas mulheres climatéricas, há dificuldades em se manter a aderência ao uso da TRH por tempo prolongado. Identificar as causas de abandono de seguimento ambulatorial e da TRH em pacientes climatéricas em uma Unidade Básica e Distrital de Saúde. Foram estudadas 158 pacientes climatéricas no período de abril de 1995 a julho de 1997. Destas 79 (50,0 por cento) usavam vários esquemas de TRH e outras 79 (50,0 por cento) näo usavam. Foi considerado abandono de seguimento a falta de retorno por mais de 6 meses após a primeira consulta, ou mais de um ano após o último retorno. As pacientes que abandonaram o seguimento ambulatorial foram submetidas a um questionário pré-estabelecido para apurar as causas do abandono. A média da idade das pacientes foi de 54,1 anos ñ 7,6 (39-74). Entre as usuárias de TRH, 74,7 por cento näo apresentaram nenhum efeito colateral e 17,7 por cento apresentaram sangramento vaginal. Onze (13,9 por cento) usuárias de TRH abandonaram o seguimento ambulatorial e também o uso da TRH. Nesse grupo os principais motivos relacionados para o abandono foram: particulares n=7 (63,6 por cento) e efeitos colaterais n=6 (54,5 por cento) especialmente sangramento vaginal. Entre as pacientes näo usuárias de TRH, 17 (21,5 por cento) abandonaram o serviço, apresentando como causa mais importante os motivos particulares n=10 (58,8 por cento). Esses dados sugerem que a falta de aderência a TRH deve-se principalmente a motivos de ordem particular, além dos efeitos colaterais. Para as pacientes näo usuárias de TRH os motivos particulares também foram os mais importantes como causa de abandono ao seguimento ambulatorial


Subject(s)
Humans , Female , Middle Aged , Climacteric , Local Health Systems , Menopause , Estrogen Replacement Therapy/statistics & numerical data , Estrogen Replacement Therapy/psychology , Estrogen Replacement Therapy , Treatment Refusal , Health Knowledge, Attitudes, Practice , Hormone Replacement Therapy
3.
Rev. méd. Chile ; 124(10): 1240-4, oct. 1996. tab
Article in Spanish | LILACS | ID: lil-185175

ABSTRACT

Forty postmenopausal women were divided in 2 groups to receive a dayli dose of 2 mg oestradiol valerate and 2,5 mg medroxyprogesterone acetate or an identical placebo during 6 months. Initially and the end of the treatment period, they were subjected to a psychiatric interview and the Graffar, Hamilton and Eysenk personality tests were applied. Also an analysis of Verbal Behavior was used, that results in hope and hopeless scores. There were no differences in the initial assessment between the 2 treatment groups. In women receiving hormonal suplementation, the Hamilton score decreased from 11.2 to 4.9 (p<0.002) and in women receiving placebo from 8.1 to 5.3 (NS). No other significant changes in psychological tests were observed. In conclusion, hormonal supplementation decreases the Hamilton depression score in postmenopausal women


Subject(s)
Humans , Female , Middle Aged , Climacteric/drug effects , Estrogen Replacement Therapy/psychology , Personality Tests , Climacteric/psychology , Depressive Disorder/epidemiology , Psychiatric Status Rating Scales , Psychological Tests
SELECTION OF CITATIONS
SEARCH DETAIL